WEKO3
アイテム
{"_buckets": {"deposit": "b37197a3-1050-4827-98a9-6887a4370de6"}, "_deposit": {"created_by": 1, "id": "48373", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "48373"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00048373", "sets": ["1"]}, "author_link": ["486192", "486194", "486198", "486202", "486197", "486196", "486191", "486199", "486200", "486193", "486195", "486204", "486201", "486203"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "35", "bibliographicPageStart": "31", "bibliographicVolumeNumber": "125", "bibliographic_titles": [{"bibliographic_title": "Radiotherapy and Oncology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "PURPOSE: \n\\nTo investigate carbon-ion radiotherapy (CIRT) for in-field recurrence of stage I non-small cell lung cancer (NSCLC) initially treated with CIRT.\n\\nMATERIALS AND METHODS: \n\\nFrom January 2007 to March 2014, patients initially treated for stage I NSCLC with CIRT and relapsed in-field were candidates. Overall survival (OS) rate, local control (LC) rate, progressive free survival (PFS) rate, dose to the lungs and skin, and adverse effects were analyzed.\n\\nRESULTS: \n\\nTwenty-nine patients were eligible. Median age at re-irradiation was 74years (range 53-90). Median observation period from the first day of re-irradiation was 29months (4-88months). Median prescribed dose was 46.0Gy (RBE) as initial treatment and 66.0Gy (RBE) in 12 fractions as re-irradiation. Two-year OS, LC, and PFS rates after re-irradiation were 69.0% (95% CI: 50.3-83.0), 66.9% (95% CI: 47.5-81.9), and 51.7% (95% CI: 34.1-68.9). Median skin maximum dose was 53.8Gy (RBE) (range 4.4-103.1) and median of mean lung dose was 7.3Gy (RBE) (range 2.6-14.0). There were no severer than grade 2 adverse effects except one (3.4%) grade 3 bacterial pneumonia, which was not considered radiation-induced.\n\\nCONCLUSION: \n\\nCIRT for stage I NSCLC local recurrence is an acceptable definitive re-treatment.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Elsevier B.V."}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "28784437", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1016/j.radonc.2017.07.022 ", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "http://dx.doi.org/10.1016/j.radonc.2017.07.022"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://dx.doi.org/10.1016/j.radonc.2017.07.022", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0167-8140", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Karube, Masataka"}], "nameIdentifiers": [{"nameIdentifier": "486191", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Naoyoshi"}], "nameIdentifiers": [{"nameIdentifier": "486192", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "486193", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kanematsu, Nobuyuki"}], "nameIdentifiers": [{"nameIdentifier": "486194", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakajima, Mio"}], "nameIdentifiers": [{"nameIdentifier": "486195", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "H, Yamashita"}], "nameIdentifiers": [{"nameIdentifier": "486196", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakagawa, K"}], "nameIdentifiers": [{"nameIdentifier": "486197", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "486198", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "軽部 雅崇", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "486199", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山本 直敬", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "486200", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "486201", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "兼松 伸幸", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "486202", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中嶋 美緒", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "486203", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "486204", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/48373", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-11-16"}, "publish_date": "2017-11-16", "publish_status": "0", "recid": "48373", "relation": {}, "relation_version_is_last": true, "title": ["Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy."], "weko_shared_id": -1}
Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.
https://repo.qst.go.jp/records/48373
https://repo.qst.go.jp/records/48373f29b52f8-e749-4403-b9ad-03552fd02aee
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-11-16 | |||||
タイトル | ||||||
タイトル | Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Karube, Masataka
× Karube, Masataka× Yamamoto, Naoyoshi× Tsuji, Hiroshi× Kanematsu, Nobuyuki× Nakajima, Mio× H, Yamashita× Nakagawa, K× Kamada, Tadashi× 軽部 雅崇× 山本 直敬× 辻 比呂志× 兼松 伸幸× 中嶋 美緒× 鎌田 正 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | PURPOSE: \nTo investigate carbon-ion radiotherapy (CIRT) for in-field recurrence of stage I non-small cell lung cancer (NSCLC) initially treated with CIRT. \nMATERIALS AND METHODS: \nFrom January 2007 to March 2014, patients initially treated for stage I NSCLC with CIRT and relapsed in-field were candidates. Overall survival (OS) rate, local control (LC) rate, progressive free survival (PFS) rate, dose to the lungs and skin, and adverse effects were analyzed. \nRESULTS: \nTwenty-nine patients were eligible. Median age at re-irradiation was 74years (range 53-90). Median observation period from the first day of re-irradiation was 29months (4-88months). Median prescribed dose was 46.0Gy (RBE) as initial treatment and 66.0Gy (RBE) in 12 fractions as re-irradiation. Two-year OS, LC, and PFS rates after re-irradiation were 69.0% (95% CI: 50.3-83.0), 66.9% (95% CI: 47.5-81.9), and 51.7% (95% CI: 34.1-68.9). Median skin maximum dose was 53.8Gy (RBE) (range 4.4-103.1) and median of mean lung dose was 7.3Gy (RBE) (range 2.6-14.0). There were no severer than grade 2 adverse effects except one (3.4%) grade 3 bacterial pneumonia, which was not considered radiation-induced. \nCONCLUSION: \nCIRT for stage I NSCLC local recurrence is an acceptable definitive re-treatment. |
|||||
書誌情報 |
Radiotherapy and Oncology 巻 125, 号 1, p. 31-35, 発行日 2017-08 |
|||||
出版者 | ||||||
出版者 | Elsevier B.V. | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0167-8140 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 28784437 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.radonc.2017.07.022 | |||||
関連サイト | ||||||
識別子タイプ | DOI | |||||
関連識別子 | http://dx.doi.org/10.1016/j.radonc.2017.07.022 | |||||
関連名称 | http://dx.doi.org/10.1016/j.radonc.2017.07.022 |